thats my problem with the real world right to try process....anyone who is willing to take an experimental drug will definitely be doing chemo and the SOC, and doctors will never attribute the turnaround to the experimental drug. even if SOC is failing and the hail mary is to try LL, the average doctor will not confirm it was LL that helped. never. i have enough experience to know that arrogant doctors are sticks cemented in mud. might as well be scientologists.
even if LL occupancy tests and other diagnostics prove that LL is doing what it is supposed to, what doctor is going to admit his treatment failed and the new one worked? uphill battle. i guess i need more insight on how other drugs have been approved in similar situations with patients taking multiple drugs at once. but if i come down with any of these nightmare conditions, you better believe im doing way way more than just chemo and keytruda.
i hope new readers here can just look at the LL covid trial timeline and not rely on the press declaring the trials as failures. the drug was working in the first 2 weeks but the FDA decided to not dose for the remaining 2 weeks of the trial and the patient went back to the diseased state. the company wanted 4 weeks of dosing. some died because of this. criminal. its like they had a baked in failure from the get go.
just curious ...prior to approval, was keytruda only given to the worst of the worst hopelessly dying cancer patients who had exhausted all other options?
even if LL occupancy tests and other diagnostics prove that LL is doing what it is supposed to, what doctor is going to admit his treatment failed and the new one worked? uphill battle. i guess i need more insight on how other drugs have been approved in similar situations with patients taking multiple drugs at once. but if i come down with any of these nightmare conditions, you better believe im doing way way more than just chemo and keytruda.
i hope new readers here can just look at the LL covid trial timeline and not rely on the press declaring the trials as failures. the drug was working in the first 2 weeks but the FDA decided to not dose for the remaining 2 weeks of the trial and the patient went back to the diseased state. the company wanted 4 weeks of dosing. some died because of this. criminal. its like they had a baked in failure from the get go.
just curious ...prior to approval, was keytruda only given to the worst of the worst hopelessly dying cancer patients who had exhausted all other options?
8
